Filing Details
- Accession Number:
- 0001562180-20-006410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-22 15:59:36
- Reporting Period:
- 2017-10-17
- Accepted Time:
- 2020-10-22 15:59:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
105770 | West Pharmaceutical Services Inc | WST | Fabricated Rubber Products, Nec (3060) | 231210010 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1139036 | J Patrick Zenner | 530 Herman O. West Drive Exton PA 19341 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-10-17 | 335 | $93.94 | 66,475 | No | 4 | P | Direct | |
Common Stock | Disposition | 2017-11-10 | 335 | $101.54 | 66,140 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-07-31 | 57 | $110.55 | 66,197 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-02-28 | 54 | $105.14 | 66,251 | No | 4 | P | Direct | |
Common Stock | Disposition | 2019-03-19 | 11 | $106.02 | 66,240 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-03-21 | 33 | $106.49 | 66,207 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-18 | 20 | $121.83 | 66,187 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-25 | 47 | $132.22 | 66,140 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | S | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary. The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales.